keyword
https://read.qxmd.com/read/38623317/managing-opioid-withdrawal-symptoms-during-the-fentanyl-crisis-a-review
#1
REVIEW
Andrea Nicole Weber, Joshua Trebach, Marielle A Brenner, Mary Margaret Thomas, Nicholas L Bormann
Illicitly manufactured fentanyl (IMF) is a significant contributor to the increasing rates of overdose-related deaths. Its high potency and lipophilicity can complicate opioid withdrawal syndromes (OWS) and the subsequent management of opioid use disorder (OUD). This scoping review aimed to collate the current OWS management of study populations seeking treatment for OWS and/or OUD directly from an unregulated opioid supply, such as IMF. Therefore, the focus was on therapeutic interventions published between January 2010 and November 2023, overlapping with the period of increasing IMF exposure...
2024: Substance Abuse and Rehabilitation
https://read.qxmd.com/read/38605429/pregabalin-induced-parkinsonism-case-report-and-review-of-the-literature
#2
JOURNAL ARTICLE
Hossam Tharwat Ali, Sara Abdelhameed Khalil, Ana Leticia Fornari Caprara, Jamir Pitton Rissardo
Pregabalin is an anti-epileptic drug approved for the treatment of neuropathic pain and focal-onset seizures. In a few cases, pregabalin was associated with parkinsonism. We present a case of a 48-year-old female who had hypertension and was on losartan 50 mg/daily. Her general practitioner prescribed pregabalin 150 mg/daily for fibromyalgia-related pain. The subject doubled the dosage without medical advice. After 5 days of the increased dosage, she started to experience difficulty and slowness in movement associated with resting tremors...
April 11, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38564124/neuropsychiatric-effects-associated-with-opioid-based-management-for-palliative-care-patients
#3
REVIEW
Alan D Kaye, Kylie Dufrene, Jada Cooley, Madeline Walker, Shivam Shah, Alex Hollander, Sahar Shekoohi, Christopher L Robinson
PURPOSE OF REVIEW: The abundance of opioids administered in the palliative care setting that was once considered a standard of care is at present necessitating that providers evaluate patients for unintentional and deleterious symptomology related to aberrant opioid use and addiction. Polypharmacy with opioids is dynamic in affecting patients neurologically, and increased amounts of prescriptions have had inimical effects, not only for the individual, but also for their families and healthcare providers...
April 2, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38539078/prevention-of-postoperative-nausea-and-vomiting-after-orthognathic-surgery-a-scoping-review
#4
REVIEW
Peng-Fei Gao, Le Zhao, Shi-Yue Li, Yue Li, Ming-Kai Chen, Jing Fu, Yang Ji
INTRODUCTION: Postoperative nausea and vomiting (PONV) is one of the most common adverse events following orthognathic surgery. It's a distressing feeling for patients and continues to be the cause of postoperative complications such as bleeding, delayed healing, and wound infection. This scoping review aims to identify effective PONV prophylaxis strategies during orthognathic surgery that have emerged in the past 15 years. METHODS: We searched Pubmed, Cochrane Controlled Register of Trials, and Embase from 2008 to May 2023...
March 28, 2024: BMC Anesthesiology
https://read.qxmd.com/read/38531021/neurodevelopmental-and-functional-outcomes-following-in-utero-exposure-to-antiseizure-medication-a-systematic-review
#5
JOURNAL ARTICLE
Eliza Honybun, Emily Cockle, Charles B Malpas, Terence J O'Brien, Frank J Vajda, Piero Perucca, Genevieve Rayner
BACKGROUND AND OBJECTIVES: To undertake a systematic review of the available literature to examine the relationship between prenatal antiseizure medication (ASM) exposure and adverse postnatal neurodevelopmental outcomes, focusing on social, emotional, behavioral, and adaptive domains of human function, and the frequency of neurodevelopmental and psychiatric disorders in ASM-exposed offspring. METHODS: Electronic searches of MEDLINE, PsychINFO, and EMBASE were conducted and limited to studies published between 1990 and 2023 in English...
April 23, 2024: Neurology
https://read.qxmd.com/read/38505500/update-on-treating-painful-diabetic-peripheral-neuropathy-a-review-of-current-us-guidelines-with-a-focus-on-the-most-recently-approved-management-options
#6
REVIEW
Theresa Mallick-Searle, Jeremy A Adler
Painful diabetic peripheral neuropathy (DPN) is a highly prevalent and disabling complication of diabetes that is often misdiagnosed and undertreated. The management of painful DPN involves treating its underlying cause via lifestyle modifications and intensive glucose control, targeting its pathogenesis, and providing symptomatic pain relief, thereby improving patient function and health-related quality of life. Four pharmacologic options are currently approved by the US Food and Drug Administration (FDA) to treat painful DPN...
2024: Journal of Pain Research
https://read.qxmd.com/read/38505138/antineuropathic-pain-management-after-orthopedic-surgery-a-systematic-review
#7
JOURNAL ARTICLE
Taylor Harder, Jacob Harder, Gracie Baum, Cameron Cox, Justin Harder, Evan Hernandez, Brendan MacKay
BACKGROUND: The opioid crisis has become a present concern in the medical field. In an effort to address these complications, antineuropathic pain medications have been considered as alternatives to prescribed opioids. OBJECTIVE: This review focuses on the analgesic effects of neuromodulators, such as gabapentin, duloxetine, and pregabalin, that provide room for less dependence on narcotic analgesics following orthopedic surgery. METHODS: During the database searches, 1,033 records were identified as a preliminary result...
2024: Orthopedic Reviews
https://read.qxmd.com/read/38482850/a-comprehensive-update-on-the-admet-considerations-for-%C3%AE-2%C3%AE-calcium-channel-ligand-medications-for-treating-restless-legs-syndrome
#8
REVIEW
Gaia Pellitteri, Salvatore Versace, Giovanni Merlino, Annacarmen Nilo, Gian Luigi Gigli, Mariarosaria Valente
INTRODUCTION: Restless legs syndrome/Willis-Ekbom disease (RLS/WED) is a sleep-related sensory-motor disorder associated with poor sleep quality and impaired daily functioning. In patients affected by chronic RLS/WED, a pharmacological therapy is recommended. International guidelines suggest to start the treatment with a α2δ calcium channel ligand in most cases, unless contraindicated. AREAS COVERED: The present review is based on an extensive Internet and PubMed search from 1986 to 2024...
March 2024: Expert Opinion on Drug Metabolism & Toxicology
https://read.qxmd.com/read/38472004/neuropathic-pain-in-burn-patients-a-common-problem-with-little-literature-a-systematic-review
#9
REVIEW
Eloise Stanton, Paul Won, Artur Manasyan, Sandeep Gurram, T Justin Gilllenwater, Haig A Yenikomshian
BACKGROUND: The prevalence of neuropathic pain (NP) in burn patients is reported in the literature to be as high as 80%1 . Given the complexity of NP in burn patients and the wide range of treatments available, a systematic review of the literature is warranted to summarize our current understanding of management and treatment of NP in this population. METHODS: This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines...
February 28, 2024: Burns
https://read.qxmd.com/read/38382648/in-vitro-models-for-neuropathic-pain-phenotypic-screening-in-brain-therapeutics
#10
REVIEW
A L Martínez, J Brea, D López, N Cosme, M Barro, X Monroy, J Burgueño, M Merlos, M I Loza
The discovery of brain therapeutics faces a significant challenge due to the low translatability of preclinical results into clinical success. To address this gap, several efforts have been made to obtain more translatable neuronal models for phenotypic screening. These models allow the selection of active compounds without predetermined knowledge of drug targets. In this review, we present an overview of various existing models within the field, examining their strengths and limitations, particularly in the context of neuropathic pain research...
April 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38377332/phenibut%C3%A2-an-illegal-food-supplement-with-psychotropic-effects-and-health-risks
#11
REVIEW
Udo Bonnet, Norbert Scherbaum, Andreas Schaper, Michael Soyka
BACKGROUND: Phenibut (β-phenyl-γ-aminobutyric acid) is an analog of the neurotransmitter gamma-aminobutyric acid (GABA). Like gabapentin and pregabalin, it inhibits α2-δ-subunits of voltage-dependent presynaptic calcium channels. The potential harm resulting from the use of these gabapentinoids is currently a matter of debate. METHODS: This review is based on pertinent publications retrieved by a selective literature search and on cases reported to the Giftinformationszentrum-Nord (GIZ-Nord), a poison information center at the University of Göttingen, Germany...
April 5, 2024: Deutsches Ärzteblatt International
https://read.qxmd.com/read/38361721/treatment-and-prevention-of-post-dural-puncture-headaches-a-systematic-review
#12
REVIEW
Rufaydah I Alatni, Rana Alsamani, Abdulelah Alqefari
Post-dural puncture headache (PDPH) is occasionally an inevitable side effect of neuraxial anesthesia, which can happen after spinal anesthesia or if an accidental dural puncture (ADP) happens during epidural anesthesia. The treatment and prevention options for PDPH differ widely from one institution to another. The management of PDPH is heterogeneous in many institutions because of the absence of clear guidelines and protocols for the management of PDPH. This study aimed to summarize all articles published during the past decade that discussed the treatment or prevention of PDPH...
January 2024: Curēus
https://read.qxmd.com/read/38355316/-fibromyalgia-are-there-any-new-approaches
#13
REVIEW
José Eduardo Martinez, Izabela Guimarães
INTRODUCTION: Approaching patients with fibromyalgia (FM) is challenging due to the limited availability of scientifically proven effective therapies. OBJECTIVE: Review the treatments in use for FM and present new knowledge that could benefit these patients. Non-pharmacological interventions are recommended as the first line of treatment: aerobic exercise, cognitive behavioral therapy and patient education, all aimed at improving pain and other symptoms. Additional approaches have been studied, such as, digital health interventions, combined treatments, noninvasive neuromodulation, and others...
February 13, 2024: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/38354597/us-generic-antiseizure-medication-supply-chain-observations-from-analysis-of-us-government-databases
#14
JOURNAL ARTICLE
Pradeep Javarayee, Jennifer Meylor, Shamshad Shahrukh, Shannon Pollock, Rene Andrade-Machado, Jeetendra Sah, Hema Patel
BACKGROUND: Generic drug manufacturing has shifted away from the U.S. in the last few decades. The medication supply chain, from manufacturers to resellers, has become increasingly globalized and complex. This has led to bottlenecks in their manufacture resulting in medication shortages. Review of this process as it pertains to antiseizure medications (ASM) shows gaps in our comprehension of its complexities. Understanding these processes will be essential for preventing medication shortages...
February 5, 2024: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/38339875/phenibut-review-and-pharmacologic-approaches-to-treating-withdrawal
#15
JOURNAL ARTICLE
Scott R Penzak, Marilyn Bulloch
β-Phenyl-γ-aminobutyric acid (phenibut) is an analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that was first synthesized in Russia in the early 1960s. It is marketed as a nootropic (smart drug) to improve cognitive performance, and to treat generalized and social anxiety, insomnia, and alcohol withdrawal. The use of phenibut is legal in the USA and it is widely available online without a prescription. Increased public awareness of phenibut has led to a growing number of reports of acute intoxication and withdrawal...
February 10, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38279728/diet-and-lifestyle-modifications-for-fibromyalgia
#16
JOURNAL ARTICLE
Caroline Metyas, Tun Tun Aung, Jennifer Cheung, Marina Joseph, Andrew M Ballester, Samy Metyas
Fibromyalgia (FM) is a complex, widespread pain disorder characterized by symptoms such as fatigue, sleep deprivation, mental fog, mood swings, and headaches. Currently, there are only three FDA-approved medications for FM patients: duloxetine, milnacipran, and pregabalin, with outcomes frequently being inadequate. This research team aims to investigate the effects of diet and lifestyle modifications on FM, with emphasis on anti-inflammatory diet, antioxidants, and gluten-free diets, as well as supplementation with Magnesium, CQ10, and Vitamin D, microbiome, sleep, exercise, and cognitive behavioral therapy...
January 24, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38250816/anticonvulsant-agents-for-treatment-of-restless-legs-syndrome-a-case-report-with-lamotrigine-and-a-review-of-the-literature
#17
JOURNAL ARTICLE
Jawad Al-Kassmy, Mohammed Alsalmi, Woojin Kang, Philippe Huot
INTRODUCTION: Restless Legs Syndrome (RLS) is a neurological disorder primarily treated with pregabalin and gabapentin, followed by dopamine agonists later in the process due to the risk of augmenting RLS symptoms. In addition, clinical reports have disclosed varying degrees of success employing other agents in patients unresponsive to traditional agents. Here, we present a patient who had success in the reduction of RLS symptoms with lamotrigine, a broad-spectrum anticonvulsant. Previously, lamotrigine had been used in 2 trials with successful treatment of RLS...
January 22, 2024: Neurologist
https://read.qxmd.com/read/38239114/gabapentinoids-and-lactation-review-of-the-literature
#18
Burcu Özalp Horsanalı, Hüsnü Yımaz, Meltem Uyar, Can Eyigör
Gabapentin and pregabalin, which belong to the gabapentinoid drug family, are widely used, especially in neuropathic pain treatment, due to their effectiveness in pain management. Although many of the comorbidities and symptoms that limit the use of gabapentinoids are clearly described in the literature, there is limited data on their use during lactation. A 33-year-old female patient was admitted to our clinic with neuropathic pain and muscle weakness in her left lower extremity following spinal anesthesia for a cesarean section...
January 2024: Journal of the Turkish Society of Algology
https://read.qxmd.com/read/38204275/treatment-modalities-for-trigeminal-neuralgia-and-the-need-for-vigilance-in-monitoring-adverse-drug-events-a-case-report
#19
Raja Narendra Divakar Addanki, Anjali Srikanth Mannava, Hemasri Velmurugan, Pugazhenthan Thangaraju
INTRODUCTION: Trigeminal neuralgia is a rare condition characterised by paroxysms of intense pain in the distribution of the trigeminal nerve. This condition significantly diminishes the patient's quality of life, and the side effects from chronic use of medications for symptomatic relief further exacerbate their distress. CASE DESCRIPTION: The case report discusses a patient diagnosed with Trigeminal Neuralgia who commenced carbamazepine treatment. The report tracks the disease's progression, medication adjustments, and the eventual emergence of vertigo due to long-term carbamazepine use...
January 9, 2024: Current Drug Safety
https://read.qxmd.com/read/38152314/gabapentinoids-a-therapeutic-review
#20
REVIEW
Akshay Athavale, Bridin Murnion
The Australian Therapeutic Goods Administration's approved indications for prescription of gabapentinoids are refractory focal epilepsy and neuropathic pain. Use of gabapentinoids outside of the approved indications is common, but evidence for this is limited, especially for chronic nonspecific back pain and nonradicular leg pain. Some effects of gabapentinoids encourage their nonmedical use (e.g. euphoria, sedation, disinhibition). Widespread nonmedical use has increased the incidence of accidental and deliberate poisonings...
December 2023: Australian Prescriber
keyword
keyword
88690
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.